Key Takeaways
- Adjusted earnings per share reached 64 cents, falling short of the 73-cent Wall Street consensus
- Revenue declined 8% from the prior year to $4.44 billion, marginally exceeding the $4.41 billion forecast
- Organic revenue declined 3%, underperforming Nielsen-tracked global retail sales by approximately 1.5 percentage points
- Management maintained its fiscal year projection: organic revenue decline of 1.5%–2%, adjusted earnings decline of 16%–20%
- Shares of GIS fell 0.8% in early trading, extending losses to 17% year-to-date in 2026 and over 34% over twelve months
General Mills delivered disappointing fiscal third-quarter results on Wednesday, missing earnings expectations despite narrowly surpassing revenue forecasts. The food giant maintained the lowered guidance it issued last month, providing no optimism for investors seeking signs of recovery.
Adjusted earnings per share totaled 64 cents, significantly below the 73-cent analyst consensus. Revenue, accounting for acquisitions and divestitures, decreased 8% compared to the same period last year, reaching $4.44 billion—slightly above the expected $4.41 billion.
Organic revenue contracted 3%—underperforming Nielsen’s global retail sales metrics by about 1.5 percentage points. This performance gap indicates the company is losing market share rather than simply facing broader economic challenges.
Shares retreated 0.8% in premarket activity after the earnings release. Before Wednesday’s announcement, GIS had already declined 17% in 2026 and more than 34% during the trailing twelve months, positioning it among the weakest performers in the packaged foods sector.
Private Label Gains Ground as Consumers Seek Value
The underlying narrative is straightforward. Cost-conscious consumers are increasingly selecting private-label and store-brand alternatives over established brands like Cheerios, Lucky Charms, and Pillsbury.
This trend has been accelerating steadily. Packaged food manufacturers that aggressively raised prices during the inflationary period are now experiencing the consequences. General Mills finds itself squarely in this predicament.
Additionally, consumer preferences are shifting away from processed and packaged foods. The rapid adoption of GLP-1 weight-loss medications has intensified this trend, influencing consumers toward modified dietary patterns.
Uncertainty surrounding consumer spending—partially connected to geopolitical instability including the Iran war—has further dampened demand for pantry essentials.
Company Maintains Previously Reduced Annual Forecast
General Mills left its full-year guidance intact, though this outlook was already reduced during last month’s update. Management continues to project organic net sales will decline 1.5% to 2% for the current fiscal year.
Adjusted operating profit and adjusted earnings per share are both anticipated to fall 16% to 20% on a constant-currency basis. This represents a significant downturn that investors have been absorbing for several months.
The unchanged forecast did little to restore confidence. With organic sales lagging retail performance metrics and earnings missing expectations amid an already challenging period, Wednesday’s report offered minimal evidence of improvement.
S&P 500 futures advanced 0.4% on Wednesday, though the benchmark index remains down 1.9% for 2026 thus far.
